Patent · US Active

Antibody compositions

US12023381B2 · kind B2 · utility

0Cited by

5References

20Claims

0Family size

Assignee

PHILOGEN S.P.A. · IT

Inventors

Giovanni Neri · Siena, IT
Camilla Bacci · Colle Ciupi, IT

Key dates

Filing date	May 25, 2022
Grant date	Jul 2, 2024
Priority date	—
Expiry date	Jul 30, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to stable formulations that can be prepared to high concentration of active agent using low amounts of detergents and to methods for producing such formulations. In particular, this invention relates to formulations containing the L19-TNFα immunocytokine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.